GPCR

equitynet selling

Structure Therapeutics Inc · NASDAQ NMS - GLOBAL MARKET

View price on Yahoo Finance ↗
Disclosed trades
1
0 buys · 1 sells
Members involved
1
Estimated volume
$8K
sum of ranges
Most recent
Oct 4, 2023
since Oct 4, 2023

Buy it with play money

Fills at the latest stored close and lands in your paper portfolio

Sign in to buy GPCR with $10,000 of play money and watch it from here.

Sign in to trade

Price, and when Congress traded it

Hollow marks where they traded, filled where the filing went public

GPCR closing price, with each disclosed trade marked at the date it happened and the date it was filed$8$54$100Oct 24Oct 25Oct 26
they tradedyou found outthe delaygreen buys · red sells

Hover a marker to see who traded and what it was worth.

If you had bought it yourself

Paid at that day's close, held ever since. No member involved.

Amount
Latest stored close.

Working it out…

Financials

As each period's own 10-K or 10-Q reported it

Market value
$5.5B
P/E
—
P/S
—
P/B
4.0×
FCF yield
-4.1%
EV/EBITDA
—
Fair value
—
Dividend yield
—

At the $25.54 close on Oct 9, 2026, against 213.66M shares and the balance sheet at Jun 30, 2026; earnings, sales and cash flow over the fiscal year to Dec 31, 2025. A ratio is left out where its denominator is not positive. Fair value is the company's own median P/E, price to sales and price to free cash flow at its last ten fiscal year ends, applied to its trailing figures, the middle of the three: its valuation against its own past, not against its growth or its rivals.

Line itemFY 2023
Dec 31, 2023
FY 2024
Dec 31, 2024
FY 2025
Dec 31, 2025
Revenue———
Gross margin———
Operating income-$102.8M-$158.2M-$176.6M
Operating margin———
Net income-$89.6M-$122.5M-$141.2M
Net margin———
EPS (diluted)-$0.81-$0.78-$0.80
Operating cash flow-$79.5M-$116.6M-$222.2M
Capital spending$2.2M$1.3M$3.6M
Free cash flow-$81.7M-$117.9M-$225.8M
Buybacks———
Dividends paid———
Cash$129.8M$169.5M$799.6M
Debt———
Shareholders' equity$453M$864.8M$1.5B
Shares outstanding139.22M171.86M212.51M

Figures come from the company's XBRL filings as the SEC publishes them. Quarters are worked out from year-to-date figures, and a fourth quarter is the year less its first nine months, which is why it has no EPS: per-share figures do not subtract. Earlier years are on today's share basis where a split has happened since. A later restatement is not mixed into a year it was never applied to, so where a 10-K restated the year before — a business sold, say — that year's fourth quarter is left blank rather than worked out across two bases. A dash means the company did not report that line under a standard tag for that period. Every filing on EDGAR.

Short interest

Shares sold short, as brokers report them to FINRA twice a month

Shares short
7.54M
at Sep 30, 2026
Of shares outstanding
3.5%
Days to cover
5.2
Since the last report
+14.2%
from 6.61M at Sep 15, 2026
Oct 15, 2024: 10.8M shares shortOct 31, 2024: 10.44M shares shortNov 15, 2024: 11.23M shares shortNov 29, 2024: 10.55M shares shortDec 13, 2024: 10.16M shares shortDec 31, 2024: 10.75M shares shortJan 15, 2025: 9.86M shares shortJan 31, 2025: 7.85M shares shortFeb 14, 2025: 6.61M shares shortFeb 28, 2025: 6.92M shares shortMar 14, 2025: 7.04M shares shortMar 31, 2025: 6.91M shares shortApr 15, 2025: 7.02M shares shortApr 30, 2025: 9.14M shares shortMay 15, 2025: 9.32M shares shortMay 30, 2025: 9.12M shares shortJun 13, 2025: 8.27M shares shortJun 30, 2025: 7.33M shares shortJul 15, 2025: 7.86M shares shortJul 31, 2025: 7.19M shares shortAug 15, 2025: 7.26M shares shortAug 29, 2025: 6.94M shares shortSep 15, 2025: 6.8M shares shortSep 30, 2025: 6.37M shares shortOct 15, 2025: 4.85M shares shortOct 31, 2025: 5.36M shares shortNov 14, 2025: 5.28M shares shortNov 28, 2025: 4.81M shares shortDec 15, 2025: 4.89M shares shortDec 31, 2025: 6.04M shares shortJan 15, 2026: 6.25M shares shortJan 30, 2026: 5.13M shares shortFeb 13, 2026: 4.93M shares shortFeb 27, 2026: 5.23M shares shortMar 13, 2026: 5.26M shares shortMar 31, 2026: 5.76M shares shortApr 15, 2026: 6.15M shares shortApr 30, 2026: 5.97M shares shortMay 15, 2026: 5.65M shares shortMay 29, 2026: 5.57M shares shortJun 15, 2026: 5.89M shares shortJun 30, 2026: 6.13M shares shortJul 15, 2026: 6.21M shares shortJul 31, 2026: 6.05M shares shortAug 14, 2026: 6.08M shares shortAug 31, 2026: 5.85M shares shortSep 15, 2026: 6.61M shares shortSep 30, 2026: 7.54M shares short
Oct 15, 2024Sep 30, 2026
Settlement dateShares shortChangeDays to cover
Sep 30, 20267.54M+14.2%5.2
Sep 15, 20266.61M+12.8%5.2
Aug 31, 20265.85M-3.7%7.9
Aug 14, 20266.08M+0.5%10.4
Jul 31, 20266.05M-2.5%11.4
Jul 15, 20266.21M+1.3%8.8
Jun 30, 20266.13M+4.0%6.3
Jun 15, 20265.89M+5.8%7.1

Largest fails to deliver, the last year

30 settlement days with at least $10,000 of shares sold and not delivered

Settlement dateSharesValue
Apr 13, 2026152.91K$8.3M
Apr 15, 2026111.56K$5.9M
Feb 6, 202623.33K$1.7M
Dec 22, 202521.69K$1.4M
Dec 9, 202516.93K$1.2M

Short interest is every broker's short position at the settlement date, reported to FINRA and published about a week and a half later; it does not say who is short. Days to cover is the short position over the average day's trading, and the share of the company is against the shares outstanding on its latest filing. A fail to deliver is the balance of shares sold and not delivered by settlement, from the SEC: it can be a short seller who never borrowed the stock, but is as often a late delivery that clears within days.

More on GPCR

Who traded it

Most active first

MemberBuysSells
Thomas CarperDE · senate—1

Every disclosure

1 in total, newest first

MemberAmount
Thomas CarperDE · senatesellspouse$1K – $15K

Follow Structure Therapeutics Inc (GPCR) by email

New trades in Structure Therapeutics Inc (GPCR) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.